Gabriele M. Cerrone, Director, 10% Owner at Accustem Sciences Inc. (ACUT), bought 24,500 shares at $1.05 ($26K) on 2022-11-18, disclosed to the SEC on 2022-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ACUT | BUY | 2025-04-10 | $25K | — | Filing → |
| ACUT | BUY | 2025-04-08 | $79K | — | Filing → |
| ACUT | BUY | 2025-01-03 | $38K | — | Filing → |